Trial intelligence / Profile preview

Remimazolam vs Propofol on Perioperative Hypothermia Under Spinal Anesthesia

NCT05574257Completed

Sponsor
Wonkwang University Hospital
Start
Feb 2022
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of remimazolam in Procedural sedation (PS) (2 arms), sponsored by Wonkwang University Hospital. Primary endpoint: The incidence of perioperartive hypothermia. Started Feb 2022; status: completed.

02

Drugs

remimazolam
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT05574257.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05574257.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call